BridgeMD
New treatment option for Endometriosis
Official title First Line Surgery or First Line Fertility Treatment Using Assisted Reproductive Technologies in Patients With Advanced Endometriosis
ClinicalTrials.gov ID: NCT07240363
What this study is testing
- What it's testing
- Endometriosis is a chronic disease affecting approximately 10% of women of reproductive age. It is strongly associated with pelvic pain and infertility.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 38, women only
You may be able to join if
- Age 18 - 38 years old
- Endometriosis AAGL stage III-IV
- Referred or eligible for ART-treatment such as IVF or ICSI, independent of infertility diagnosis (28) (including sperm donation cycles for social...
- Body mass index 18-35 kg/m2
- Patients who have signed an approved Informed Consent
You likely can't join if
- Previous surgery for endometriosis except diagnostic laparoscopy.
- Previous IVF/ICSI-cycles (including prior fertility preservation cycles)
- Hemato- and/or hydrosalpinx
- Clear indication for surgery such as ureteral stenosis or intestinal sub-occlusive symptoms
- Suspicion of malignancy
- Submucosal fibroids (The International Federation of Gynecology and Obstetrics (FIGO) 0-1, any size) or intramural fibroids (FIGO 2-5, \> 4 cm...
See the full eligibility criteria
- Age 18 - 38 years old
- Endometriosis AAGL stage III-IV
- Referred or eligible for ART-treatment such as IVF or ICSI, independent of infertility diagnosis (28) (including sperm donation cycles for social reasons) and/or infertility due to dyspareunia/dysmenorrhea caused by...
- Body mass index 18-35 kg/m2
- Patients who have signed an approved Informed Consent
- Previous surgery for endometriosis except diagnostic laparoscopy.
- Previous IVF/ICSI-cycles (including prior fertility preservation cycles)
- Hemato- and/or hydrosalpinx
- Clear indication for surgery such as ureteral stenosis or intestinal sub-occlusive symptoms
- Suspicion of malignancy
- Submucosal fibroids (The International Federation of Gynecology and Obstetrics (FIGO) 0-1, any size) or intramural fibroids (FIGO 2-5, \> 4 cm largest diameter of the largest myoma) (29)
- Uterine malformations (class U1-U6 according to ESHRE/ESGE-classification) (30)
- Patients with contraindications to surgery
- Patients undergoing ART with donated oocytes
The study team makes the final eligibility decision.
Where it's taking place
- Stockholm, Stockholm County, Sweden
- Gothenburg, Västra Götaland County, Sweden
- Malmö, Sweden
- Uppsala, Sweden
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 38 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Stockholm, Stockholm County, Sweden; Gothenburg, Västra Götaland County, Sweden; Malmö, Sweden; Uppsala, Sweden. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.